NASDAQ:CHRS
Coherus BioSciences Stock News
$2.12
-0.0500 (-2.30%)
At Close: May 17, 2024
CHRS Stock: Why It Increased Yesterday And Today
09:26am, Thursday, 09'th Sep 2021
The stock price of Coherus BioSciences, Inc. (Nasdaq: CHRS) increased 3.71% yesterday and is up more than 1% pre-market today. This is why it happened.
Coherus BioSciences Announces New Employment Inducement Grants
04:15pm, Friday, 27'th Aug 2021
REDWOOD CITY, Calif., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective Aug. 26, 2021, the compensation com
New Strong Sell Stocks for August 25th
11:34am, Wednesday, 25'th Aug 2021
BEEM, CHRS, KMDA, STIM and PHUN have been added to the Zacks Rank #5 (Strong Sell) List on August 25, 2021
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone –
New Strong Sell Stocks for August 17th
10:39am, Tuesday, 17'th Aug 2021
ACCD, CHRS, ELVT, FLGT, and GSHD have been added to the Zacks Rank #5 (Strong Sell) List on August 17, 2021.
Coherus BioSciences, Inc. (CHRS) CEO Dennis Lanfear on Q2 2021 Results - Earnings Call Transcript
12:14pm, Sunday, 08'th Aug 2021
Coherus BioSciences, Inc. (CHRS) CEO Dennis Lanfear on Q2 2021 Results - Earnings Call Transcript
Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates
07:01pm, Thursday, 05'th Aug 2021
Coherus BioSciences (CHRS) delivered earnings and revenue surprises of -60.00% and 6.05%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Coherus BioSciences (CHRS) to Report a Decline in Earnings: What to Look Out for
04:47pm, Thursday, 29'th Jul 2021
Coherus BioSciences (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th
04:31pm, Monday, 26'th Jul 2021
REDWOOD CITY, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2021 financial results will be released after m
Coherus BioSciences Announces New Employment Inducement Grants
08:29pm, Monday, 12'th Jul 2021
REDWOOD CITY, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective July 6, 2021, the compensation comm
Coherus, Junshi Toripalimab-Chemo Combo Beat Chemo Alone in Late-Stage Nose & Throat Cancer Trial
10:01am, Friday, 04'th Jun 2021
Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ: CHRS) have announced positive results from the pivotal Phase 3 JUPITER-02 trial evaluating toripalimab plus chemotherapy fo
CHRS Stock Price: Over 10% Increase Pre-Market Explanation
07:53am, Friday, 04'th Jun 2021
The stock price of Coherus Biosciences Inc (NASDAQ: CHRS) increased by over 10% pre-market. This is why it happened.
IYH: Healthcare Dashboard For May
03:31pm, Monday, 17'th May 2021
IYH: Healthcare Dashboard For May
Coherus BioSciences, Inc. (CHRS) CEO Dennis Lanfear on Q1 2021 Results - Earnings Call Transcript
01:44am, Monday, 10'th May 2021
Coherus BioSciences, Inc. (CHRS) CEO Dennis Lanfear on Q1 2021 Results - Earnings Call Transcript
Coherus BioSciences to Present at the Bank of America Health Care Conference
04:01pm, Friday, 07'th May 2021
REDWOOD CITY, Calif., May 07, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the upcoming Bank of America Heal
